Annual FCF
-$29.65 M
-$3.56 M-13.63%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual free cash flow is -$29.65 million, with the most recent change of -$3.56 million (-13.63%) on December 31, 2023.
- During the last 3 years, EFTR annual FCF has fallen by -$43.33 million (-316.70%).
- EFTR annual FCF is now -316.70% below its all-time high of $13.68 million, reached on December 31, 2020.
Performance
EFTR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$7.28 M
-$1.66 M-29.50%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly free cash flow is -$7.28 million, with the most recent change of -$1.66 million (-29.50%) on March 31, 2024.
- Over the past year, EFTR quarterly FCF has increased by +$372.00 thousand (+4.86%).
- EFTR quarterly FCF is now -61.20% below its all-time high of -$4.51 million, reached on June 30, 2022.
Performance
EFTR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$29.27 M
+$372.00 K+1.25%
March 31, 2024
Summary
- As of February 8, 2025, EFTR TTM free cash flow is -$29.27 million, with the most recent change of +$372.00 thousand (+1.25%) on March 31, 2024.
- Over the past year, EFTR TTM FCF has dropped by -$2.09 million (-7.68%).
- EFTR TTM FCF is now -485.85% below its all-time high of -$5.00 million, reached on March 31, 2021.
Performance
EFTR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EFTR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.6% | +4.9% | -7.7% |
| 3 y3 years | -316.7% | +4.9% | -7.7% |
| 5 y5 years | -316.7% | +4.9% | -7.7% |
EFTR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | at low | -61.2% | +15.6% | -20.3% | +6.5% |
| 5 y | 5-year | -316.7% | at low | -61.2% | +19.8% | -485.9% | +6.5% |
| alltime | all time | -316.7% | at low | -61.2% | +19.8% | -485.9% | +6.5% |
EFFECTOR Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$7.28 M(+29.5%) | -$29.27 M(-1.3%) |
| Dec 2023 | -$29.65 M(+13.6%) | -$5.62 M(-27.5%) | -$29.65 M(-3.8%) |
| Sep 2023 | - | -$7.76 M(-10.0%) | -$30.82 M(-1.5%) |
| Jun 2023 | - | -$8.62 M(+12.7%) | -$31.29 M(+15.1%) |
| Mar 2023 | - | -$7.65 M(+12.6%) | -$27.19 M(+4.2%) |
| Dec 2022 | -$26.09 M | -$6.79 M(-17.5%) | -$26.09 M(+7.2%) |
| Sep 2022 | - | -$8.23 M(+82.3%) | -$24.34 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$4.51 M(-31.1%) | -$25.19 M(-4.9%) |
| Mar 2022 | - | -$6.55 M(+29.9%) | -$26.49 M(+6.2%) |
| Dec 2021 | -$24.93 M(-282.2%) | -$5.04 M(-44.4%) | -$24.93 M(+25.4%) |
| Sep 2021 | - | -$9.07 M(+56.0%) | -$19.89 M(+83.9%) |
| Jun 2021 | - | -$5.82 M(+16.4%) | -$10.81 M(+116.4%) |
| Mar 2021 | - | -$5.00 M | -$5.00 M |
| Dec 2020 | $13.68 M | - | - |
FAQ
- What is eFFECTOR Therapeutics annual free cash flow?
- What is the all time high annual FCF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual FCF year-on-year change?
- What is eFFECTOR Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly FCF year-on-year change?
- What is eFFECTOR Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM FCF year-on-year change?
What is eFFECTOR Therapeutics annual free cash flow?
The current annual FCF of EFTR is -$29.65 M
What is the all time high annual FCF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual free cash flow is $13.68 M
What is eFFECTOR Therapeutics annual FCF year-on-year change?
Over the past year, EFTR annual free cash flow has changed by -$3.56 M (-13.63%)
What is eFFECTOR Therapeutics quarterly free cash flow?
The current quarterly FCF of EFTR is -$7.28 M
What is the all time high quarterly FCF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly free cash flow is -$4.51 M
What is eFFECTOR Therapeutics quarterly FCF year-on-year change?
Over the past year, EFTR quarterly free cash flow has changed by +$372.00 K (+4.86%)
What is eFFECTOR Therapeutics TTM free cash flow?
The current TTM FCF of EFTR is -$29.27 M
What is the all time high TTM FCF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM free cash flow is -$5.00 M
What is eFFECTOR Therapeutics TTM FCF year-on-year change?
Over the past year, EFTR TTM free cash flow has changed by -$2.09 M (-7.68%)